288 related articles for article (PubMed ID: 15899037)
1. Histone deacetylase inhibitors modulate metalloproteinase gene expression in chondrocytes and block cartilage resorption.
Young DA; Lakey RL; Pennington CJ; Jones D; Kevorkian L; Edwards DR; Cawston TE; Clark IM
Arthritis Res Ther; 2005; 7(3):R503-12. PubMed ID: 15899037
[TBL] [Abstract][Full Text] [Related]
2. Effects of glucocorticoids and interleukin-1 beta on expression and activity of aggrecanases in equine chondrocytes.
Busschers E; Holt JP; Richardson DW
Am J Vet Res; 2010 Feb; 71(2):176-85. PubMed ID: 20113225
[TBL] [Abstract][Full Text] [Related]
3. Metalloproteinase and inhibitor expression profiling of resorbing cartilage reveals pro-collagenase activation as a critical step for collagenolysis.
Milner JM; Rowan AD; Cawston TE; Young DA
Arthritis Res Ther; 2006; 8(5):R142. PubMed ID: 16919164
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylases--a new target for suppression of cartilage degradation?
Mort JS
Arthritis Res Ther; 2005; 7(4):155-6. PubMed ID: 15987498
[TBL] [Abstract][Full Text] [Related]
5. Collagen degradation products modulate matrix metalloproteinase expression in cultured articular chondrocytes.
Fichter M; Körner U; Schömburg J; Jennings L; Cole AA; Mollenhauer J
J Orthop Res; 2006 Jan; 24(1):63-70. PubMed ID: 16419970
[TBL] [Abstract][Full Text] [Related]
6. Mithramycin downregulates proinflammatory cytokine-induced matrix metalloproteinase gene expression in articular chondrocytes.
Liacini A; Sylvester J; Li WQ; Zafarullah M
Arthritis Res Ther; 2005; 7(4):R777-83. PubMed ID: 15987479
[TBL] [Abstract][Full Text] [Related]
7. Class I histone deacetylase inhibition modulates metalloproteinase expression and blocks cytokine-induced cartilage degradation.
Culley KL; Hui W; Barter MJ; Davidson RK; Swingler TE; Destrument AP; Scott JL; Donell ST; Fenwick S; Rowan AD; Young DA; Clark IM
Arthritis Rheum; 2013 Jul; 65(7):1822-30. PubMed ID: 23575963
[TBL] [Abstract][Full Text] [Related]
8. Activation of cartilage matrix metalloproteinases by activated protein C.
Jackson MT; Smith MM; Smith SM; Jackson CJ; Xue M; Little CB
Arthritis Rheum; 2009 Mar; 60(3):780-91. PubMed ID: 19248107
[TBL] [Abstract][Full Text] [Related]
9. Sulfasalazine blocks the release of proteoglycan and collagen from cytokine stimulated cartilage and down-regulates metalloproteinases.
Lakey RL; Cawston TE
Rheumatology (Oxford); 2009 Oct; 48(10):1208-12. PubMed ID: 19690126
[TBL] [Abstract][Full Text] [Related]
10. Retinoic acid and oncostatin M combine to promote cartilage degradation via matrix metalloproteinase-13 expression in bovine but not human chondrocytes.
Shingleton WD; Jones D; Xu X; Cawston TE; Rowan AD
Rheumatology (Oxford); 2006 Aug; 45(8):958-65. PubMed ID: 16467367
[TBL] [Abstract][Full Text] [Related]
11. Peptides of type II collagen can induce the cleavage of type II collagen and aggrecan in articular cartilage.
Yasuda T; Tchetina E; Ohsawa K; Roughley PJ; Wu W; Mousa A; Ionescu M; Pidoux I; Poole AR
Matrix Biol; 2006 Sep; 25(7):419-29. PubMed ID: 16919430
[TBL] [Abstract][Full Text] [Related]
12. Differential Toll-like receptor-dependent collagenase expression in chondrocytes.
Zhang Q; Hui W; Litherland GJ; Barter MJ; Davidson R; Darrah C; Donell ST; Clark IM; Cawston TE; Robinson JH; Rowan AD; Young DA
Ann Rheum Dis; 2008 Nov; 67(11):1633-41. PubMed ID: 18258708
[TBL] [Abstract][Full Text] [Related]
13. Effects of alendronate on a disintegrin and metalloproteinase with thrombospondin motifs expression in the developing epiphyseal cartilage in rats.
Kim MS; Kim JH; Lee MR; Kang JH; Kim HJ; Ko HM; Choi CH; Jung JY; Koh JT; Kim BK; Oh HK; Kim WJ; Lee EJ; Kim SH
Anat Histol Embryol; 2009 Apr; 38(2):154-60. PubMed ID: 19183348
[TBL] [Abstract][Full Text] [Related]
14. Modulation of the expression of matrix metalloproteinase and tissue inhibitors of metalloproteinases by TGF-beta1 and IGF-1 in primary human articular and bovine nasal chondrocytes stimulated with TNF-alpha.
Hui W; Rowan AD; Cawston T
Cytokine; 2001 Oct; 16(1):31-5. PubMed ID: 11669584
[TBL] [Abstract][Full Text] [Related]
15. 17β-estradiol reduces expression of MMP-1, -3, and -13 in human primary articular chondrocytes from female patients cultured in a three dimensional alginate system.
Claassen H; Steffen R; Hassenpflug J; Varoga D; Wruck CJ; Brandenburg LO; Pufe T
Cell Tissue Res; 2010 Nov; 342(2):283-93. PubMed ID: 20941509
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase inhibitor up-regulates RECK to inhibit MMP-2 activation and cancer cell invasion.
Liu LT; Chang HC; Chiang LC; Hung WC
Cancer Res; 2003 Jun; 63(12):3069-72. PubMed ID: 12810630
[TBL] [Abstract][Full Text] [Related]
17. Effects of culture conditions and exposure to catabolic stimulators (IL-1 and retinoic acid) on the expression of matrix metalloproteinases (MMPs) and disintegrin metalloproteinases (ADAMs) by articular cartilage chondrocytes.
Flannery CR; Little CB; Caterson B; Hughes CE
Matrix Biol; 1999 Jun; 18(3):225-37. PubMed ID: 10429942
[TBL] [Abstract][Full Text] [Related]
18. Activation of procollagenases is a key control point in cartilage collagen degradation: interaction of serine and metalloproteinase pathways.
Milner JM; Elliott SF; Cawston TE
Arthritis Rheum; 2001 Sep; 44(9):2084-96. PubMed ID: 11592371
[TBL] [Abstract][Full Text] [Related]
19. Comparative effects of 2 antioxidants, selenomethionine and epigallocatechin-gallate, on catabolic and anabolic gene expression of articular chondrocytes.
Andriamanalijaona R; Kypriotou M; Baugé C; Renard E; Legendre F; Raoudi M; Boumediene K; Gatto H; Monginoux P; Pujol JP
J Rheumatol; 2005 Oct; 32(10):1958-67. PubMed ID: 16206353
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of histone deacetylases antagonized FGF2 and IL-1beta effects on MMP expression in human articular chondrocytes.
Wang X; Song Y; Jacobi JL; Tuan RS
Growth Factors; 2009 Feb; 27(1):40-9. PubMed ID: 19107653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
